The Effectiveness of Varicella Vaccination in Children in Germany

NCT00679796 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1012

Last updated 2012-10-29

No results posted yet for this study

Summary

This study is undertaken to evaluate the effectiveness of currently licensed varicella vaccines under conditions of routine use in a setting where varicella vaccine is included in the childhood immunization calendar.

Conditions

  • Varicella (Chickenpox)
  • Chickenpox Vaccines

Interventions

PROCEDURE

Varicella (chickenpox) lesion sampling

Sponsors & Collaborators

  • Ludwig-Maximilians - University of Munich

    collaborator OTHER
  • GlaxoSmithKline

    lead INDUSTRY

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00679796 on ClinicalTrials.gov